We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Cellomics Announces Distribution Partner in China

By Biotechdaily staff writers
Posted on 23 Sep 2004
Cellomics, Inc. More...
(Pittsburgh, PA, USA) has announced that its distribution partner in China is Shanghai AnXing Scientific Instrument & Materials Import & Export Co., Ltd. (AnXing).

AnXing will provide sales, marketing, service, and customer support for Cellomics products, including the ArrayScan and KineticScan HCS (high content screening) readers, BioApplications image analysis software, a suite of high-content informatics (Hci) software and a portfolio of HitKit HCS reagent kits. These products are used in drug discovery and systems biology research.

"Anxing is a terrific partner, given their strong position in the life science market in China, coupled with exceptional service and support capability to ensure our new customers can implement our technology,” commented Daniel J. Calvo, president and CEO of Cellomics.

AnXing states that its mission is to provide the Chinese market with the latest technology as well as equipment for bioscience and biotechnology. The company will continue to act as a link between the technology and the users in order to facilitate the development of the Chinese biotechnology industry.





Related Links:
Cellomics
AnXing

New
Gold Member
Aspiration System
VACUSAFE
New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Repetitive Pipette
VWR® Stepper Pro
New
Prefilled Tubes
Prefilled 5.0ml Tubes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.